80 results
6-K
EX-99.1
PRFX
PainReform Ltd
26 Jun 24
PainReform Completes Enrollment in the Second Part
4:15pm
, non-opioid pain management solution to patients and healthcare providers. This innovative drug candidate leverages a patented, oil-based, extended … ropivacaine, targeting the postoperative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly
6-K
EX-99.1
PRFX
PainReform Ltd
31 May 24
PainReform Announces Receipt of Nasdaq Minimum Bid Price Notification
4:24pm
-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed prior to closure
6-K
EX-99.2
PRFX
PainReform Ltd
15 May 24
Condensed Financial Statements
4:15pm
relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed prior to closure to provide
6-K
EX-99.3
PRFX
PainReform Ltd
15 May 24
Condensed Financial Statements
4:15pm
the postoperative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed prior
424B4
PRFX
PainReform Ltd
17 Apr 24
Prospectus supplement with pricing info
4:14pm
candidate, is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution
6-K
EX-99.1
90avzugy8682zz4l9
16 Apr 24
PainReform Announces Pricing of $4 Million Public Offering
8:17am
F-1/A
czxay5gpm3h
15 Apr 24
Registration statement (foreign) (amended)
9:41am
6-K
EX-99.1
m7f ejwm15zjzs5
9 Apr 24
Current report (foreign)
9:07am
6-K
EX-99.1
k0u3g5g2idqj
2 Apr 24
PainReform Reaches 50% Enrollment in the Second Part of its Phase 3 Clinical
8:35am
POS AM
wz5d49l2tgn0v2uqodwl
13 Mar 24
Prospectus update (post-effective amendment)
8:00am
F-1
kcj6b7i o5yd6wq
1 Mar 24
Registration statement (foreign)
4:34pm
6-K
EX-99.1
zm6i22g lqieof
1 Mar 24
PainReform Provides Year-End Business Update
8:09am
424B3
1701ez
19 Jan 24
Prospectus supplement
4:30pm
F-3
jv7u0ro6oayn
12 Jan 24
Shelf registration (foreign)
4:15pm
6-K
EX-99.1
k4o4qr5 ns750jmn00n
3 Jan 24
PainReform Reports Successful Head-to-Head Comparison
8:36am
6-K
EX-99.1
f6un8j0go i6
26 Dec 23
PainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross
6:08pm
6-K
EX-99.3
2ndi naj2
15 Nov 23
Condensed Financial Statements
4:09pm
6-K
EX-99.2
a2u230o
15 Nov 23
Condensed Financial Statements
4:09pm
6-K
EX-99.1
oee7wyb
11 Sep 23
Trial completion and results expected in mid-2024
8:41am